CTLA-4 blockade shifts the B cell repertoire toward autoimmunity.

Saved in:
Bibliographic Details
Title: CTLA-4 blockade shifts the B cell repertoire toward autoimmunity.
Authors: Çakan E; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Wang M; Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, USA., Dai Y; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Mirouse A; Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Villanueva-Pachas CR; Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Bouis D; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Boeckers JM; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Gera R; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Yraita S; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Clapp L; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Perdigoto AL; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, Connecticut, USA., Delmotte FR; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Massad C; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Bacchiocchi A; Department of Dermatology., Ring AM; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Kluger Y; Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, USA.; Department of Pathology., Kluger HM; Yale Center for Immuno-Oncology.; Yale Cancer Center, and.; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Herold KC; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yale University, New Haven, Connecticut, USA., Meffre E; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.; Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2025 Sep 30; Vol. 135 (22). Date of Electronic Publication: 2025 Sep 30 (Print Publication: 2025).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI189074